Clinical trial registry record

Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 5, 2016.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT01477086
Last registry update
February 5, 2016
Status
Completed
Phase
Phase not reported
Sponsor
Hospital Viamed Valvanera, Spain
Enrollment
198
Countries
Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
198
Population
ALL · 65 Years
Duration
2012-01-01 to 2015-12-01
Intervention
Comparator
Not reported
Outcomes measured
Sarcopenia prevalence — Within the first 72 hours of admission.; Relationship inflammatory indices and sarcopenia. — A admission and at discharge, after 30 days.; Prevalence of falls. — During the six months prior to admission.; Acute mortality. — During admission; Relationship sarcopenia and frailty. — At admission and after 30 days.; Relationship sarcopenia and Barthel index. — At admission and after 30 days .
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: elderly. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON